MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stojilkovic, S. S.
Right arrow Articles by Catt, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stojilkovic, S. S.
Right arrow Articles by Catt, K. J.

Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator

SS Stojilkovic, M Tomic, M Kukuljan and KJ Catt

Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

The mechanisms by which the generation and frequency of cytoplasmic Ca2+ oscillations are controlled were investigated in pituitary gonadotrophs. In these cells, two Ca(2+)-mobilizing receptors, the gonadotropin-releasing hormone and endothelin receptors, induce frequency-modulated Ca2+ spiking at the rate of up to 30 min-1. The cytoplasmic oscillator is also activated by discharge of luminal Ca2+ (initiated by ionomycin, thapsigargin, or thimerosal) but not by increased voltage-sensitive Ca2+ influx or treatment with caffeine. The basic difference between these two types of Ca2+ oscillations is related to their requirement for inositol-1,4,5-triphosphate (InsP3). Thapsigargin-, thimerosal-, and ionomycin-induced spiking occurs without the rise in InsP3 production that is essential for the generation of receptor-controlled oscillatory responses. The differential requirement for InsP3 in the two types of Ca2+ spiking is indicated by two lines of evidence. First, agonist-induced Ca2+ spiking of frequency similar to that of non-receptor-mediated oscillations was accompanied by a significant increase in InsP3, whereas none of the non- receptor-mediated oscillations was associated with measurable changes in inositol phosphate production. Second, agonist-induced InsP3 formation and Ca2+ spiking were abolished by treatment with the phospholipase C inhibitors U73122 and neomycin sulfate, whereas non- receptor-mediated Ca2+ spiking was not affected by these agents. When the oscillator was activated by agents that do not increase InsP3 formation, it operated only at the basal rate of approximately 5 min-1 and spiking frequency did not rise with increasing drug concentrations, in contrast to the situation in agonist-stimulated gonadotrophs. However, both types of oscillations were affected by depletion of luminal Ca2+ and by changes in the intracellular Ca2+ concentration ([Ca2+]i) but were not inhibited by ryanodine. These findings are consistent with the operation of a single-pool Ca2+ oscillator that is responsible for generation of both types of Ca2+ oscillations. The oscillator is controlled by the coagonist actions of InsP3 and Ca2+ on the InsP3 receptor channels and by the activation of Ca(2+)-ATPase by rising [Ca2+]i. It can be induced to operate at low frequency without an increase in InsP3 production by agents that reduce intraluminal [Ca2+]i, and it exhibits a dose-dependent increase in spiking frequency during agonist stimulation.

Volume 45, Issue 5, pp. 1013-1021, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J EndocrinolHome page
H. L Henderson, J. Townsend, and D. J Tortonese
Direct effects of prolactin and dopamine on the gonadotroph response to GnRH
J. Endocrinol., May 1, 2008; 197(2): 343 - 350.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Zemkova, A. Balik, Y. Jiang, K. Kretschmannova, and S. S. Stojilkovic
Roles of Purinergic P2X Receptors as Pacemaking Channels and Modulators of Calcium-Mobilizing Pathway in Pituitary Gonadotrophs
Mol. Endocrinol., June 1, 2006; 20(6): 1423 - 1436.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. Barhoumi, Y. Mouneimne, I. Awooda, S. H. Safe, K. C. Donnelly, and R. C. Burghardt
Characterization of Calcium Oscillations in Normal and Benzo[a]pyrene-Treated Clone 9 Cells
Toxicol. Sci., August 1, 2002; 68(2): 444 - 450.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Harris, D. Bonfil, D. CHuderland, S. Kraus, R. Seger, and Z. Naor
Activation of MAPK Cascades by GnRH: ERK and Jun N-Terminal Kinase Are Involved in Basal and GnRH-Stimulated Activity of the Glycoprotein Hormone LH{beta}-Subunit Promoter
Endocrinology, March 1, 2002; 143(3): 1018 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Neural Comput.Home page
L. N. Cornelisse, W. J. J. M. Scheenen, W. J. H. Koopman, E. W. Roubos, and S. C. A. M. Gielen
Minimal Model for Intracellular Calcium Oscillations and Electrical Bursting in Melanotrope Cells of Xenopus Laevis
Neural Comput., January 1, 2001; 13(1): 113 - 137.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Zemkova and J. VanecEK
Differences in Gonadotropin-Releasing Hormone-Induced Calcium Signaling between Melatonin-Sensitive and Melatonin-Insensitive Neonatal Rat Gonadotrophs
Endocrinology, March 1, 2000; 141(3): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Zivadinovic, F. Van Goor, D. Yuan, T.-a. Koshimizu, and S. S. Stojilkovic
Expression of Ca2+-Mobilizing EndothelinA Receptors and Their Role in the Control of Ca2+ Influx and Growth Hormone Secretion in Pituitary Somatotrophs
J. Neurosci., September 15, 1999; 19(18): 7721 - 7731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Charles, E. T. Piros, C. J. Evans, and T. G. Hales
L-type Ca2+ Channels and K+ Channels Specifically Modulate the Frequency and Amplitude of Spontaneous Ca2+ Oscillations and Have Distinct Roles in Prolactin Release in GH3 Cells
J. Biol. Chem., March 12, 1999; 274(11): 7508 - 7515.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Rabadan-Diehl and G. Aguilera
Glucocorticoids Increase Vasopressin V1b Receptor Coupling to Phospholipase C
Endocrinology, July 1, 1998; 139(7): 3220 - 3226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Jobin, L. A. Vergara, and S. S. Stojilkovic
Expression of Purinergic Receptor Channels and Their Role in Calcium Signaling and Hormone Release in Pituitary Gonadotrophs. INTEGRATION OF P2 CHANNELS IN PLASMA MEMBRANE- AND ENDOPLASMIC RETICULUM-DERIVED CALCIUM OSCILLATIONS
J. Biol. Chem., August 30, 1996; 271(35): 21200 - 21208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Van Goor, D. Zivadinovic, A. J. Martinez-Fuentes, and S. S. Stojilkovic
Dependence of Pituitary Hormone Secretion on the Pattern of Spontaneus Voltage-gated Calcium Influx. CELL TYPE-SPECIFIC ACTION POTENTIAL SECRETION COUPLING
J. Biol. Chem., August 31, 2001; 276(36): 33840 - 33846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. D. Johnson, C. J. H. Wong, W. K. Yunker, and J. P. Chang
Caffeine-stimulated GTH-II release involves Ca2+ stores with novel properties
Am J Physiol Cell Physiol, March 1, 2002; 282(3): C635 - C645.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics